Rockland Trust
WST icon

Rockland Trust’s West Pharmaceutical WST Stock Holding History

Rockland Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$776K Sell
2,094
-862
-29% -$304K 0.03% 177
2026
Q2 		$1.06M Sell
2,956
-1,287
-30% -$393K 0.04% 142
2026
Q1 		$1.06M Sell
4,243
-1,920
-31% -$478K 0.04% 141
2025
Q4 		$1.7M Sell
6,163
-76,903
-93% -$21M 0.07% 116
2025
Q3 		$21.8M Buy
83,066
+5,087
+7% +$1.24M 0.89% 37
2025
Q2 		$17.1M Buy
77,979
+13,255
+20% +$2.83M 0.83% 40
2025
Q1 		$14.5M Buy
64,724
+4,980
+8% +$1.37M 0.73% 44
2024
Q4 		$19.6M Buy
59,744
+3,102
+5% +$976K 1% 34
2024
Q3 		$17M Buy
56,642
+3,055
+6% +$936K 0.84% 41
2024
Q2 		$17.7M Buy
53,587
+1,153
+2% +$407K 0.93% 35
2024
Q1 		$20.7M Buy
52,434
+400
+0.8% +$148K 1.09% 32
2023
Q4 		$18.3M Buy
52,034
+243
+0.5% +$86K 1% 35
2023
Q3 		$19.4M Sell
51,791
-574
-1% -$222K 1.17% 27
2023
Q2 		$20M Sell
52,365
-1,021
-2% -$365K 1.2% 25
2023
Q1 		$18.5M Buy
53,386
+7,316
+16% +$2.14M 1.16% 25
2022
Q4 		$10.8M Sell
46,070
-3,780
-8% -$896K 0.69% 51
2022
Q3 		$12.3M Buy
49,850
+1,446
+3% +$441K 0.88% 43
2022
Q2 		$14.6M Buy
48,404
+47,130
+3,699% +$15.3M 1.01% 32
2022
Q1 		$523K Buy
1,274
+26
+2% +$10.2K 0.03% 202
2021
Q4 		$585K Sell
1,248
-245
-16% -$105K 0.04% 196
2021
Q3 		$634K Hold
1,493
– – 0.04% 181
2021
Q2 		$536K Buy
+1,493
New +$493K 0.04% 193

Other funds holding WST

ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Conestoga Capital Advisors
Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return

Rockland Trust's WST Position: Q3 2026 in Review

Rockland Trust reduced its West Pharmaceutical (WST) stake by 29% in Q3 2026, selling an estimated $304K and leaving 2,094 shares worth $776K. The position accounts for 0.03% of the portfolio, ranked #177.

Rockland Trust first reported a position in WST in Q2 2021 and has held it in 22 quarters since. The position peaked at $21.8M in Q3 2025. 321 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Rockland Trust held 2,094 shares of West Pharmaceutical worth $776K as of Q3 2026.
  • Rockland Trust sold 862 West Pharmaceutical shares in Q3 2026, an estimated $304K.
  • West Pharmaceutical made up 0.03% of Rockland Trust's portfolio in Q3 2026, its #177 holding.
  • Rockland Trust first reported a position in West Pharmaceutical in Q2 2021 and has held it in 22 quarters since.
  • Rockland Trust's West Pharmaceutical position peaked at $21.8M in Q3 2025.
  • 321 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Rockland Trust's 13F filing for Q3 2026, filed 5 Oct 2026.